NeuPath Health Inc. closes on previously announced brokered offering of C$1.453M of subordinated and postponed unsecured non-convertible debentures
May 2, 2023
1.45 Million CAD
On May 2, 2023, NeuPath Health Inc. (the “Company”), announced it has closed its previously announced brokered private placement offering of 10% subordinated and postponed unsecured non-convertible debenture units of the Company (the “Units”) for gross proceeds of C$1.453 million (the “Offering”).The Offering was led by Bloom Burton Securities Inc. as lead agent and Hampton Securities Ltd. (collectively, the “Agents”).
The Bloom Burton Securities Inc. exists to provide investors with curated investment vehicles that deliver a diversified portfolio of healthcare companies in a single investment.
McCarthy Tétrault advised Bloom Burton Securities Inc. with a team led by Philippe Leclerc that included Mireille Trottier (Business).